Cardiology drugs
18 results
Attruby (acoramidis hydrochloride)
(acoramidis hydrochloride)BridgeBio Pharma, Inc.
Usage: ATTRUBY is indicated for treating cardiomyopathy associated with wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults, aiming to reduce cardiovascular death and related hospitalizations.
Auvi-q (epinephrine)
(epinephrine)kaleo, Inc
Usage: AUVI-Q® is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis from various allergens such as insect stings, foods, drugs, and exercise. It is meant for immediate self-administration in individuals at increased risk of anaphylaxis and is not a substitute for medical care.
Azor (amlodipine besylate and olmesartan medoxomil)
(amlodipine besylate and olmesartan medoxomil)Daiichi Sankyo Inc.
Usage: Azor is indicated for treating hypertension, either alone or in combination with other antihypertensive agents, to lower blood pressure and reduce the risk of cardiovascular events like strokes and heart attacks. It may also serve as initial therapy for patients likely needing multiple antihypertensive medications.
Benicar (olmesartan medoxomil)
(olmesartan medoxomil)Cosette Pharmaceuticals, Inc.
Usage: Benicar is indicated for the treatment of hypertension in adults and children aged six and older. It helps lower blood pressure, reducing the risk of cardiovascular events like strokes and myocardial infarctions. It may be used alone or in combination with other antihypertensive agents as part of comprehensive cardiovascular management.
Benicar hct (olmesartan medoxomil-hydrochlorothiazide)
(olmesartan medoxomil-hydrochlorothiazide)Cosette Pharmaceuticals, Inc.
Usage: BENICAR HCT, containing olmesartan medoxomil and hydrochlorothiazide, is indicated for the treatment of hypertension to lower blood pressure. It is not meant for initial therapy and can be used alone or with other antihypertensive medications, contributing to reduced cardiovascular risks associated with high blood pressure.
Bystolic (nebivolol hydrochloride)
(nebivolol hydrochloride)Allergan, Inc.
Usage: BYSTOLIC is indicated for the treatment of hypertension to lower blood pressure, either alone or in combination with other antihypertensive agents. It aids in reducing the risk of cardiovascular events, such as strokes and myocardial infarctions, as part of comprehensive cardiovascular risk management.
Camzyos (mavacamten)
(mavacamten)Myokardia, Inc.
Usage: CAMZYOS® is indicated for adults with symptomatic NYHA class II-III obstructive hypertrophic cardiomyopathy (HCM) to enhance functional capacity and alleviate symptoms.
Cleviprex (clevipidine)
(clevipidine)Chiesi USA, Inc.
Usage: Cleviprex is indicated for reducing blood pressure in patients when oral therapy is not feasible or desirable.
Edarbi (azilsartan kamedoxomil)
(Azilsartan kamedoxomil)Azurity Pharmaceuticals, Inc.
Usage: Edarbi is indicated for the treatment of hypertension in adults to lower blood pressure, thereby reducing the risk of cardiovascular events such as strokes and myocardial infarctions. It can be used alone or in combination with other antihypertensive medications as part of comprehensive cardiovascular risk management.
Edarbyclor (azilsartan kamedoxomil and chlorthalidone)
(Azilsartan kamedoxomil and chlorthalidone)Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Usage: Edarbyclor is indicated for treating hypertension to lower blood pressure, particularly in patients not adequately controlled on monotherapy. It may also serve as initial therapy for those likely needing multiple drugs to achieve blood pressure goals, reducing cardiovascular event risks associated with high blood pressure.